查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972869

溶脂注射市場：市場洞察、競爭格局及預測（2033年）

Injection Lipolysis Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 183 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計未來幾年，溶脂注射市場將穩定成長，這主要得益於消費者對非侵入性美容手術日益成長的興趣以及對塑形方案認知度的提高。市場規模預計在2026年達到 13.3億美元，到2033年將達到 18億美元，年複合成長率（CAGR）為 4.3%。這一成長凸顯了微創治療的趨勢，與傳統手術相比，微創治療能夠更精準地減少脂肪，且恢復時間更短。

市場概覽

溶脂注射是一種利用藥物注射來針對局部脂肪堆積的治療方法。它能夠分解脂肪細胞，並透過人體自身的代謝過程促進脂肪的排出。最常用的藥物包括脫氧膽酸和磷脂醯膽鹼，它們都具有溶脂特性。由於其微創性、副作用少以及對包括腹部、大腿、上臂和頦下區域在內的多個治療部位的有效性，該療法備受關注。藥物輸送技術的創新和配方的改進進一步提升了治療效果，增強了患者的信任度和接受度。

主要市場驅動因子

以下因素推動溶脂注射市場的擴張：

  • 1.美容意識的增強 - 社群媒體的影響、名人代言以及人們對自身外表日益成長的關注，推動了人們對無需侵入性手術即可獲得明顯效果的美容療法的需求。
  • 2.非手術療法的偏好 - 由於疼痛感更輕、併發症風險更低、恢復時間更短，患者日益尋求抽脂和其他外科減脂方法的替代方案。
  • 3.美容診所和門診治療中心的擴張 - 專業皮膚科和美容機構的增加，使得更多患者能夠接受溶脂注射療法。
  • 4.技術進步 - 更安全、更有效的注射技術和藥物的持續研發，提高了治療效率和病人滿意度。
  • 5.人口趨勢 - 全球人口老化推動了對頑固脂肪堆積和與年齡相關的身體變化解決方案的需求，創造了新的市場需求。

新機會

溶脂注射市場為現有企業和新進業者提供了眾多機會。對新型溶脂化合物、更安全的配方和先進的給藥系統進行研發，可以帶來顯著的競爭優勢。與皮膚科和美容診所建立合作關係，並進行強調微創手術的定向行銷活動，可以進一步促進溶脂注射療法的普及。新興市場也蘊藏著巨大的潛力，因為可支配收入的成長和人們對美容手術認知度的提高催生新的消費群體。

主要商機包括：

  • 開發新一代注射劑，以提高療效並減少副作用。
  • 建立專門從事非手術塑形治療的機構。
  • 利用數位行銷和社群媒體平台，向病患普及溶脂注射劑的益處。
  • 與健康和預防保健機構合作，將美容療程納入綜合健康計劃。

區域洞察

北美地區在全球注射溶脂市場中處於領先地位，這得益於該地區對美容手術的高度認知、先進的醫療基礎設施以及對創新療法的積極應用。美國仍是重要的市場貢獻者，各大公司持續投資於研發、行銷和分銷網路。

歐洲，尤其是德國、法國和英國等國家，擁有巨大的成長潛力，這主要得益於患者對微創美容解決方案的需求，以及確保安全性和有效性的嚴格監管標準。

亞太地區預計將實現最快成長，這主要得益於可支配收入的增加、中產階級人口的壯大以及人們對非手術美容程序的認知度不斷提高。中國、印度和韓國成為該地區的關鍵市場。

溶脂注射在拉丁美洲和中東、非洲地區正逐漸流行。這些地區的成長得益於因美容目的而進行的國際旅行的增加，以及提供先進塑形服務的美容和皮膚科診所數量的增加。

競爭格局

全球溶脂注射市場競爭激烈，跨國公司和區域公司都在推動創新並擴大其業務範圍。該市場的主要營運公司包括：

  • Allergan (AbbVie)
  • Cynosure (Hologic)
  • Galderma
  • Merz Aesthetics
  • SBC Aesthetic
  • Suneva Medical
  • Dermatech Corporation
  • Teoxane Laboratories
  • Biotech Pharma Group
  • Sculpture Aesthetic
  • Lumenis
  • BTL Aesthetics
  • InMode (Alma Lasers)
  • Cutera, Inc.
  • Revanesse (Prollenium Medical)

這些公司正致力於產品創新、策略聯盟、併購和地理擴張，以獲取市場佔有率並滿足日益成長的非侵入性減脂治療需求。

市場區隔

依藥物類型：

  • 脫氧膽酸
  • 磷脂醯膽鹼
  • 其他

依治療部位：

  • 臉部脂肪
  • 頦下脂肪
  • 上臂脂肪
  • 腹部脂肪
  • 大腿脂肪
  • 膝蓋脂肪
  • 臀部脂肪
  • 其他

依最終用戶：

  • 醫院
  • 皮膚科和美容診所
  • 門診手術中心

依地區：

  • 北美
  • 拉丁美洲美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲

目錄

第1章 執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 驅動因素
    • 限制因素
    • 市場機會
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監理分析
  • 價格趨勢分析
    • 當前價格及未來預測（2025-2033年）
    • 價格影響因素

第3章 全球溶脂注射劑市場預測，2020-2033

  • 全球溶脂注射劑市場預，依藥物類型測，價值（十億美元），2020-2033
    • 脫氧膽酸
    • 磷脂醯膽鹼
    • 其他
  • 全球溶脂注射劑市場預測，依治療部位，價值（十億美元），2020-2033
    • 臉部脂肪
    • 頦下脂肪
    • 上臂脂肪
    • 腹部脂肪
    • 大腿脂肪
    • 膝蓋脂肪
    • 臀部脂肪
    • 其他
  • 全球溶脂注射劑市場預測，依最終用戶，價值（美元） （十億美元），2020-2033年
    • 醫院
    • 皮膚科和美容診所
    • 門診手術中心
  • 全球溶脂注射市場預測，依地區，價值（十億美元），2020-2033年
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章 北美溶脂注射市場展望，2020-2033年

第5章 歐洲溶脂注射市場展望，2020-2033年

第6章 亞太地區溶脂注射市場展望，2020-2033

第7章 拉丁美洲溶脂注射劑市場展望，2020-2033年

第8章 中東與非洲溶脂注射劑市場展望，2020-2033年

第9章 競爭格局

  • 公司與細分市場熱圖
  • 公司市場佔有率分析，2025年
  • 競爭格局概覽
  • 公司簡介
    • Allergan (AbbVie)
    • Cynosure (Hologic)
    • Galderma
    • Merz Aesthetics
    • SBC Aesthetic
    • Suneva Medical
    • Dermatech Corporation
    • Teoxane Laboratories
    • Biotech Pharma Group
    • Sculpture Aesthetic

第10章 附錄

簡介目錄

The Injection Lipolysis Market is projected to experience steady growth over the coming years, driven by increasing consumer interest in non-invasive cosmetic procedures and heightened awareness of body contouring solutions. The market is estimated at USD 1.33 billion in 2026 and is expected to grow to USD 1.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.3%. This growth highlights the shift toward minimally invasive treatments that deliver targeted fat reduction with reduced recovery times compared to traditional surgical options.

Market Overview

Injection lipolysis is a procedure designed to target localized fat deposits using pharmaceutical injections, which break down fat cells for natural elimination by the body. The most widely used agents include deoxycholic acid and phosphatidylcholine, both known for their fat-dissolving properties. The procedure has gained traction due to its minimally invasive nature, limited side effects, and effectiveness across multiple treatment areas such as the abdomen, thighs, upper arms, and submental region. Innovations in drug delivery techniques and formulation improvements have further enhanced treatment outcomes, boosting patient confidence and adoption rates.

Key Market Drivers

Several factors are driving the expansion of the injection lipolysis market:

  • 1. Growing Aesthetic Awareness - Social media influence, celebrity endorsements, and rising interest in personal appearance have fueled demand for cosmetic treatments that provide visible results without invasive surgery.
  • 2. Preference for Non-Surgical Procedures - Patients increasingly seek alternatives to liposuction and other surgical fat reduction methods due to reduced pain, lower complication risks, and shorter recovery periods.
  • 3. Expansion of Cosmetic Clinics and Ambulatory Centers - The proliferation of specialized dermatology and cosmetic centers has made injection lipolysis more accessible to a wider population.
  • 4. Technological Advancements - Continuous development of safer and more effective injection techniques and formulations has improved treatment efficiency and patient satisfaction.
  • 5. Demographic Trends - The aging global population is increasingly seeking solutions for stubborn fat deposits and age-related body contour changes, creating additional demand.

Emerging Opportunities

The injection lipolysis market offers numerous opportunities for both established companies and new entrants. Research and development aimed at new fat-dissolving compounds, safer formulations, and advanced delivery systems can provide significant competitive advantages. Collaborations with dermatology and cosmetic clinics, along with targeted marketing campaigns emphasizing minimally invasive procedures, can further drive adoption. Emerging markets also offer promising potential, as growing disposable incomes and awareness of aesthetic procedures create new consumer bases.

Key business opportunities include:

  • Development of next-generation injectable compounds with higher efficacy and fewer side effects.
  • Establishing specialized centers focused exclusively on non-surgical body contouring treatments.
  • Leveraging digital marketing and social media platforms to educate patients on the benefits of injection lipolysis.
  • Partnering with wellness and preventive healthcare providers to integrate cosmetic treatments into broader wellness programs.

Regional Insights

North America leads the global injection lipolysis market due to high awareness of aesthetic procedures, advanced healthcare infrastructure, and strong adoption of innovative treatment options. The United States remains a key contributor, with major players investing in research, marketing, and distribution networks.

Europe shows significant growth potential, particularly in countries such as Germany, France, and the United Kingdom, driven by patient demand for minimally invasive cosmetic solutions and strict regulatory standards that ensure safety and efficacy.

Asia Pacific is anticipated to register the fastest growth, fueled by increasing disposable income, growing middle-class populations, and rising awareness of non-surgical aesthetic procedures. China, India, and South Korea are emerging as key markets in this region.

Latin America and the Middle East & Africa are gradually adopting injection lipolysis treatments. Growth in these regions is supported by rising aesthetic tourism and an increasing number of cosmetic and dermatology clinics offering advanced body contouring services.

Competitive Landscape

The global injection lipolysis market is competitive, with a mix of multinational corporations and regional players driving innovation and expanding reach. Key companies operating in this market include:

  • Allergan (AbbVie)
  • Cynosure (Hologic)
  • Galderma
  • Merz Aesthetics
  • SBC Aesthetic
  • Suneva Medical
  • Dermatech Corporation
  • Teoxane Laboratories
  • Biotech Pharma Group
  • Sculpture Aesthetic
  • Lumenis
  • BTL Aesthetics
  • InMode (Alma Lasers)
  • Cutera, Inc.
  • Revanesse (Prollenium Medical)

These players focus on product innovation, strategic alliances, mergers, and geographic expansion to capture market share and meet the growing demand for non-invasive fat reduction treatments.

Market Segmentation

By Drug Type:

  • Deoxycholic Acid
  • Phosphatidylcholine
  • Others

By Treatment Site:

  • Facial Fat Deposits
  • Submental Fat
  • Upper Arm Fat
  • Abdominal Fat
  • Thighs Fat
  • Knee Fat
  • Buttock Fat
  • Others

By End-User:

  • Hospitals
  • Dermatology and Cosmetic Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Injection Lipolysis Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Injection Lipolysis Market Outlook, 2020-2033

  • 3.1. Global Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Deoxycholic Acid
    • 3.1.2. Phosphatidylcholine
    • 3.1.3. Others
  • 3.2. Global Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 3.2.1. Facial Fat Deposits
    • 3.2.2. Submental Fat
    • 3.2.3. Upper Arm Fat
    • 3.2.4. Abdominal Fat
    • 3.2.5. Thighs Fat
    • 3.2.6. Knee Fat
    • 3.2.7. Buttock Fat
    • 3.2.8. Others
  • 3.3. Global Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Dermatology and Cosmetic Clinics
    • 3.3.3. Ambulatory Surgical Centers
  • 3.4. Global Injection Lipolysis Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Injection Lipolysis Market Outlook, 2020-2033

  • 4.1. North America Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Deoxycholic Acid
    • 4.1.2. Phosphatidylcholine
    • 4.1.3. Others
  • 4.2. North America Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 4.2.1. Facial Fat Deposits
    • 4.2.2. Submental Fat
    • 4.2.3. Upper Arm Fat
    • 4.2.4. Abdominal Fat
    • 4.2.5. Thighs Fat
    • 4.2.6. Knee Fat
    • 4.2.7. Buttock Fat
    • 4.2.8. Others
  • 4.3. North America Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Dermatology and Cosmetic Clinics
    • 4.3.3. Ambulatory Surgical Centers
  • 4.4. North America Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 4.4.2. U.S. Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 4.4.3. U.S. Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 4.4.4. Canada Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 4.4.5. Canada Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 4.4.6. Canada Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Injection Lipolysis Market Outlook, 2020-2033

  • 5.1. Europe Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Deoxycholic Acid
    • 5.1.2. Phosphatidylcholine
    • 5.1.3. Others
  • 5.2. Europe Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 5.2.1. Facial Fat Deposits
    • 5.2.2. Submental Fat
    • 5.2.3. Upper Arm Fat
    • 5.2.4. Abdominal Fat
    • 5.2.5. Thighs Fat
    • 5.2.6. Knee Fat
    • 5.2.7. Buttock Fat
    • 5.2.8. Others
  • 5.3. Europe Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Dermatology and Cosmetic Clinics
    • 5.3.3. Ambulatory Surgical Centers
  • 5.4. Europe Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.2. Germany Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.3. Germany Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.4. Italy Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.5. Italy Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.6. Italy Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.7. France Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.8. France Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.9. France Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.10. U.K. Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.11. U.K. Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.12. U.K. Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.13. Spain Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.14. Spain Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.15. Spain Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.16. Russia Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.17. Russia Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.18. Russia Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 5.4.19. Rest of Europe Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 5.4.20. Rest of Europe Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 5.4.21. Rest of Europe Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Injection Lipolysis Market Outlook, 2020-2033

  • 6.1. Asia Pacific Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Deoxycholic Acid
    • 6.1.2. Phosphatidylcholine
    • 6.1.3. Others
  • 6.2. Asia Pacific Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 6.2.1. Facial Fat Deposits
    • 6.2.2. Submental Fat
    • 6.2.3. Upper Arm Fat
    • 6.2.4. Abdominal Fat
    • 6.2.5. Thighs Fat
    • 6.2.6. Knee Fat
    • 6.2.7. Buttock Fat
    • 6.2.8. Others
  • 6.3. Asia Pacific Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Dermatology and Cosmetic Clinics
    • 6.3.3. Ambulatory Surgical Centers
  • 6.4. Asia Pacific Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.2. China Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.3. China Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.4. Japan Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.5. Japan Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.6. Japan Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.7. South Korea Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.8. South Korea Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.9. South Korea Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.10. India Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.11. India Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.12. India Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.13. Southeast Asia Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.14. Southeast Asia Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.15. Southeast Asia Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 6.4.16. Rest of SAO Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 6.4.17. Rest of SAO Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 6.4.18. Rest of SAO Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Injection Lipolysis Market Outlook, 2020-2033

  • 7.1. Latin America Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Deoxycholic Acid
    • 7.1.2. Phosphatidylcholine
    • 7.1.3. Others
  • 7.2. Latin America Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 7.2.1. Facial Fat Deposits
    • 7.2.2. Submental Fat
    • 7.2.3. Upper Arm Fat
    • 7.2.4. Abdominal Fat
    • 7.2.5. Thighs Fat
    • 7.2.6. Knee Fat
    • 7.2.7. Buttock Fat
    • 7.2.8. Others
  • 7.3. Latin America Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Dermatology and Cosmetic Clinics
    • 7.3.3. Ambulatory Surgical Centers
  • 7.4. Latin America Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.2. Brazil Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.3. Brazil Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.4.4. Mexico Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.5. Mexico Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.6. Mexico Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.4.7. Argentina Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.8. Argentina Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.9. Argentina Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 7.4.10. Rest of LATAM Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 7.4.11. Rest of LATAM Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 7.4.12. Rest of LATAM Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Injection Lipolysis Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Injection Lipolysis Market Outlook, by Drug Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Deoxycholic Acid
    • 8.1.2. Phosphatidylcholine
    • 8.1.3. Others
  • 8.2. Middle East & Africa Injection Lipolysis Market Outlook, by Treatment Site, Value (US$ Bn), 2020-2033
    • 8.2.1. Facial Fat Deposits
    • 8.2.2. Submental Fat
    • 8.2.3. Upper Arm Fat
    • 8.2.4. Abdominal Fat
    • 8.2.5. Thighs Fat
    • 8.2.6. Knee Fat
    • 8.2.7. Buttock Fat
    • 8.2.8. Others
  • 8.3. Middle East & Africa Injection Lipolysis Market Outlook, by End-user, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Dermatology and Cosmetic Clinics
    • 8.3.3. Ambulatory Surgical Centers
  • 8.4. Middle East & Africa Injection Lipolysis Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.2. GCC Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.3. GCC Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.4. South Africa Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.5. South Africa Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.6. South Africa Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.7. Egypt Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.8. Egypt Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.9. Egypt Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.10. Nigeria Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.11. Nigeria Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.12. Nigeria Injection Lipolysis Market Outlook, by End-user, 2020-2033
    • 8.4.13. Rest of Middle East Injection Lipolysis Market Outlook, by Drug Type, 2020-2033
    • 8.4.14. Rest of Middle East Injection Lipolysis Market Outlook, by Treatment Site, 2020-2033
    • 8.4.15. Rest of Middle East Injection Lipolysis Market Outlook, by End-user, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Allergan (AbbVie)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Cynosure (Hologic)
    • 9.4.3. Galderma
    • 9.4.4. Merz Aesthetics
    • 9.4.5. SBC Aesthetic
    • 9.4.6. Suneva Medical
    • 9.4.7. Dermatech Corporation
    • 9.4.8. Teoxane Laboratories
    • 9.4.9. Biotech Pharma Group
    • 9.4.10. Sculpture Aesthetic

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations